Moshe Laudon

5.8k total citations
81 papers, 4.6k citations indexed

About

Moshe Laudon is a scholar working on Endocrine and Autonomic Systems, Cognitive Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, Moshe Laudon has authored 81 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Endocrine and Autonomic Systems, 34 papers in Cognitive Neuroscience and 26 papers in Experimental and Cognitive Psychology. Recurrent topics in Moshe Laudon's work include Circadian rhythm and melatonin (62 papers), Sleep and Wakefulness Research (33 papers) and Sleep and related disorders (26 papers). Moshe Laudon is often cited by papers focused on Circadian rhythm and melatonin (62 papers), Sleep and Wakefulness Research (33 papers) and Sleep and related disorders (26 papers). Moshe Laudon collaborates with scholars based in Israel, China and United States. Moshe Laudon's co-authors include Nava Zisapel, Doron Garfinkel, Tali Nir, Yaacov Egozi, Paula Herer, Peretz Lavie, Iris Haimov, Ian Ford, I. Nir and Alan Wade and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Moshe Laudon

81 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moshe Laudon Israel 39 3.1k 1.9k 1.8k 747 461 81 4.6k
Daniel P. Cardinali Argentina 27 2.0k 0.6× 755 0.4× 526 0.3× 653 0.9× 580 1.3× 90 3.1k
Jonathan R.S. Arch United Kingdom 37 2.3k 0.7× 1.4k 0.7× 795 0.4× 2.4k 3.2× 634 1.4× 75 5.7k
Tetsuo Shimizu Japan 35 1.2k 0.4× 1.4k 0.7× 1.3k 0.7× 601 0.8× 853 1.9× 175 4.4k
Jocelyne Brun France 26 1.7k 0.6× 672 0.3× 666 0.4× 626 0.8× 200 0.4× 55 2.7k
Margaret Moline United States 35 1.3k 0.4× 1.5k 0.8× 1.8k 1.0× 627 0.8× 152 0.3× 140 3.8k
Andrea Rodenbeck Germany 34 1.3k 0.4× 1.6k 0.8× 1.7k 0.9× 580 0.8× 170 0.4× 95 3.1k
Andrew N. Coogan Ireland 37 1.7k 0.5× 942 0.5× 887 0.5× 713 1.0× 677 1.5× 96 3.8k
Palmiero Monteleone Italy 50 2.3k 0.7× 952 0.5× 769 0.4× 1.3k 1.8× 934 2.0× 253 8.1k
Jaime M. Monti Uruguay 40 1.9k 0.6× 3.2k 1.7× 2.0k 1.1× 414 0.6× 1.4k 3.0× 156 5.3k
David Michelson United States 37 822 0.3× 1.6k 0.9× 1.2k 0.7× 815 1.1× 605 1.3× 69 5.6k

Countries citing papers authored by Moshe Laudon

Since Specialization
Citations

This map shows the geographic impact of Moshe Laudon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Laudon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Laudon more than expected).

Fields of papers citing papers by Moshe Laudon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshe Laudon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Laudon. The network helps show where Moshe Laudon may publish in the future.

Co-authorship network of co-authors of Moshe Laudon

This figure shows the co-authorship network connecting the top 25 collaborators of Moshe Laudon. A scholar is included among the top collaborators of Moshe Laudon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshe Laudon. Moshe Laudon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schneider, Lon S., Moshe Laudon, Tali Nir, et al.. (2021). A Polymorphism Cluster at the 2q12 locus May Predict Response to Piromelatine in Patients with Mild Alzheimer's Disease. The Journal of Prevention of Alzheimer s Disease. 9(2). 247–254. 12 indexed citations
3.
Fu, Wan, et al.. (2016). Piromelatine ameliorates memory deficits associated with chronic mild stress-induced anhedonia in rats. Psychopharmacology. 233(12). 2229–2239. 32 indexed citations
4.
Zielińska, Marta, Maciej Sałaga, Radzisław Kordek, et al.. (2016). Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 389(5). 511–519. 17 indexed citations
5.
Farmer, Mildred V., Gil Harari, Naama Fund, et al.. (2014). Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Hu, Xiaobo, Chi Zhang, Shenghua Yang, et al.. (2014). Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats. European Journal of Pharmacology. 727. 60–65. 29 indexed citations
7.
Wang, Pingping, et al.. (2013). Piromelatine decreases triglyceride accumulation in insulin resistant 3T3-L1 adipocytes: Role of ATGL and HSL. Biochimie. 95(8). 1650–1654. 18 indexed citations
8.
Paulis, Ludovít, Fedor Šimko, & Moshe Laudon. (2012). Cardiovascular effects of melatonin receptor agonists. Expert Opinion on Investigational Drugs. 21(11). 1661–1678. 52 indexed citations
9.
Leersnyder, Hélène De, Nava Zisapel, & Moshe Laudon. (2011). Prolonged-Release Melatonin for Children With Neurodevelopmental Disorders. Pediatric Neurology. 45(1). 23–26. 51 indexed citations
10.
11.
Lemoine, Patrick, Tali Nir, Moshe Laudon, & Nava Zisapel. (2007). Prolonged‐release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. Journal of Sleep Research. 16(4). 372–380. 186 indexed citations
12.
Léger, Damien, Moshe Laudon, & Nava Zisapel. (2004). Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. The American Journal of Medicine. 116(2). 91–95. 127 indexed citations
13.
Ferber, Sari Goldstein, Moshe Laudon, Jacob Kuint, Aron Weller, & Nava Zisapel. (2002). Massage Therapy by Mothers Enhances the Adjustment of Circadian Rhythms to the Nocturnal Period in Full-Term Infants. Journal of Developmental & Behavioral Pediatrics. 23(6). 410–415. 55 indexed citations
14.
Sivan, Yakov, et al.. (2000). Low melatonin production in infants with a life-threatening event. Developmental Medicine & Child Neurology. 42(7). 487–491. 15 indexed citations
15.
Shamir, Eyal, Vadim S. Rotenberg, Moshe Laudon, Nava Zisapel, & Avner Elizur. (2000). First-Night Effect of Melatonin Treatment in Patients With Chronic Schizophrenia. Journal of Clinical Psychopharmacology. 20(6). 691–694. 30 indexed citations
16.
Garfinkel, Doron, Nava Zisapel, Julio Wainstein, & Moshe Laudon. (1999). Facilitation of Benzodiazepine Discontinuation by Melatonin. Archives of Internal Medicine. 159(20). 2456–2456. 89 indexed citations
17.
Haimov, Iris, Moshe Laudon, Nava Zisapel, et al.. (1994). Sleep disorders and melatonin rhythms in elderly people. BMJ. 309(6948). 167–167. 247 indexed citations
18.
Laudon, Moshe & Nava Zisapel. (1991). Melatonin binding proteins identified in the rat brain by affinity labeling. FEBS Letters. 288(1-2). 105–108. 7 indexed citations
19.
Laudon, Moshe, Daniel Grossman, & Nira Ben‐Jonathan. (1990). Prolactin-Releasing Factor: Cellular Origin in the Intermediate Lobe of the Pituitary*. Endocrinology. 126(6). 3185–3192. 40 indexed citations
20.
Laudon, Moshe, Z. Yaron, & Nava Zisapel. (1988). N-(3,5-dinitrophenyl)-5-methoxytryptamine, a novel melatonin antagonist: effects on sexual maturation of the male and female rat and on oestrous cycles of the female rat. Journal of Endocrinology. 116(1). 43–53. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel P. Cardinali Breakdown of academic impact, for papers by Jonathan R.S. Arch Breakdown of academic impact, for papers by Tetsuo Shimizu Breakdown of academic impact, for papers by Jocelyne Brun Breakdown of academic impact, for papers by Margaret Moline Breakdown of academic impact, for papers by Andrea Rodenbeck Breakdown of academic impact, for papers by Andrew N. Coogan Breakdown of academic impact, for papers by Palmiero Monteleone Breakdown of academic impact, for papers by Jaime M. Monti Breakdown of academic impact, for papers by David Michelson
Rankless by CCL
2026